203 related articles for article (PubMed ID: 9066856)
1. FDA posts record number of drug approvals in 1996.
Am J Health Syst Pharm; 1997 Mar; 54(5):494, 497-8. PubMed ID: 9066856
[No Abstract] [Full Text] [Related]
2. Priority drugs well represented among 1998 approvals. FDA says all performance goals were met.
Miller JL
Am J Health Syst Pharm; 1999 Mar; 56(5):408, 411-2. PubMed ID: 10096697
[No Abstract] [Full Text] [Related]
3. Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration.
Jiao K; Gupta R; Fox E; Kesselheim A; Ross JS
JAMA Netw Open; 2019 Oct; 2(10):e1913029. PubMed ID: 31603482
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of rare disease marketing applications associated with FDA product approvals 2006-2010.
Pariser AR; Slack DJ; Bauer LJ; Warner CA; Tracy LA
Drug Discov Today; 2012 Aug; 17(15-16):898-904. PubMed ID: 22564486
[TBL] [Abstract][Full Text] [Related]
5. Mid-year at the FDA highlights permanent problem.
Howard K
Nat Rev Drug Discov; 2004 Aug; 3(8):637. PubMed ID: 15317145
[No Abstract] [Full Text] [Related]
6. Muddied messages about FDA.
Miller HI
Nat Biotechnol; 2003 Jul; 21(7):732-3. PubMed ID: 12833084
[No Abstract] [Full Text] [Related]
7. 2017 Is Banner Year for Drug Approvals by the Food and Drug Administration.
Ebied AM; Cooper-DeHoff RM
Am J Med; 2018 Sep; 131(9):1025-1033. PubMed ID: 29626430
[TBL] [Abstract][Full Text] [Related]
8. Has the COVID-19 Crisis Affected the Growth of United States Food and Drug Administration Drug Approvals? The Answer is Not Yet! A Time Series (Forecasting) Study.
Daizadeh I
Ther Innov Regul Sci; 2021 May; 55(3):553-557. PubMed ID: 33367967
[TBL] [Abstract][Full Text] [Related]
9. New Drug Approvals in 2018 - Another Record Year!
Ebied AM; Na J; Cooper-DeHoff RM
Am J Med; 2019 Sep; 132(9):1038-1043. PubMed ID: 30853471
[TBL] [Abstract][Full Text] [Related]
10. 2014 in review: FDA approval of new drugs.
Kinch MS
Drug Discov Today; 2017 Apr; 22(4):620-624. PubMed ID: 26100738
[TBL] [Abstract][Full Text] [Related]
11. Significant FDA approvals in 2000.
McGinnis TJ
Am Fam Physician; 2001 May; 63(10):2061-4. PubMed ID: 11388719
[No Abstract] [Full Text] [Related]
12. A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and Why.
Kashoki M; Hanaizi Z; Yordanova S; Veselý R; Bouygues C; Llinares J; Kweder SL
Clin Pharmacol Ther; 2020 Jan; 107(1):195-202. PubMed ID: 31306483
[TBL] [Abstract][Full Text] [Related]
13. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
14. Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada.
Lythgoe MP; Middleton P
JAMA Netw Open; 2021 Jun; 4(6):e2114531. PubMed ID: 34170306
[TBL] [Abstract][Full Text] [Related]
15. Assessing tumor-related signs and symptoms to support cancer drug approval.
Williams G; Pazdur R; Temple R
J Biopharm Stat; 2004 Feb; 14(1):5-21. PubMed ID: 15027497
[TBL] [Abstract][Full Text] [Related]
16. Making medical progress. A look at FDA approvals in 2000.
FDA Consum; 2001; 35(2):7-8. PubMed ID: 11444251
[No Abstract] [Full Text] [Related]
17. New FDA breakthrough-drug category--implications for patients.
Darrow JJ; Avorn J; Kesselheim AS
N Engl J Med; 2014 Mar; 370(13):1252-8. PubMed ID: 24670173
[No Abstract] [Full Text] [Related]
18. FDA new drug approvals in Q1 2020.
Urquhart L
Nat Rev Drug Discov; 2020 May; 19(5):299. PubMed ID: 32296148
[No Abstract] [Full Text] [Related]
19. FDA new drug approvals in Q3 2020.
Urquhart L
Nat Rev Drug Discov; 2020 Nov; 19(11):746. PubMed ID: 33046853
[No Abstract] [Full Text] [Related]
20. FDA new drug approvals in 2003.
Wynn RL
Gen Dent; 2004; 52(4):294-8, 300. PubMed ID: 15366292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
